- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 22.10. | AstraZeneca's Breztri TV spot sets sail, creating tailwind for COPD drug's cruise up the sales charts | ||
| 21.10. | Radiopharma CDMO Nucleus lays out plan to triple manufacturing capacity, add 100 jobs | ||
| 21.10. | ICER raises cost-effective price for Pfizer's ATTR drug in final analysis but still calls for hefty discount | ||
| 21.10. | Sanofi in 'exclusive negotiations' to sell 50% stake in €16B consumer health unit Opella | ||
| 21.10. | Activist investor Starboard sets its sights on J&J spinout Kenvue: WSJ | ||
| 21.10. | Takeda details another round of layoffs in Massachusetts as restructuring drive rolls on | ||
| 21.10. | Novo plots US, EU approval filings after oral semaglutide shows cardio benefits in certain diabetes patients | ||
| 18.10. | Astellas nabs class-first FDA approval for CLDN18.2 gastric cancer med Vyloy | ||
| 18.10. | Lilly joins OAC campaign against obesity stigma, partnering on gallery of bias-free images for use in media coverage | ||
| 18.10. | EU drug reviewers back Novo Nordisk's FDA-rejected hemophilia drug, snub PTC's Translarna again | ||
| 18.10. | Baxter to import 18,000 tons of IV product by year-end as hurricane recovery efforts continue in NC | ||
| 18.10. | Novo Holdings' $16.5B Catalent buyout in crosshairs as consumer groups ask FTC to block the deal | ||
| 18.10. | Gilead pulls Trodelvy's approval in bladder cancer after trial flop, FDA discussions | ||
| 18.10. | Fierce Pharma Asia-Lilly's China expansions; Gilead's scrapped MASH deal; Leqembi's vial scrutiny | ||
| 17.10. | Novartis falls short in legal effort to undo FDA approval of MSN's Entresto generic | ||
| 17.10. | Tarsus taps actor Betsy Sodaro to embody a 'mitey problem' in 1st Xdemvy DTC TV ad | ||
| 17.10. | NIH study shows Bavarian Nordic's mpox shot elicits immune response in teens | ||
| 17.10. | Eli Lilly shows how public restroom rarity affects ulcerative colitis patients | ||
| 17.10. | 3rd time's the charm: AbbVie scores FDA nod for continuous Parkinson's disease therapy Vyalev | ||
| 17.10. | Viatris makes good on CEO's dealmaking promise with $25M licensing pact for Lexicon's heart med Inpefa | ||
| 17.10. | Canadian CDMO OmniaBio debuts new cell and gene therapy manufacturing facility | ||
| 17.10. | CDMO SpectronRx homes in on completion of European plant to crank out key isotope for radiotherapies | ||
| 17.10. | ABPI finds familiarity breeds trust, supporting push for industry-healthcare collaborations | ||
| 16.10. | Johnson & Johnson sets 'new standard in inclusive marketing' with diverse Tremfya psoriasis ad | ||
| 16.10. | With Gilead coming fast, GSK bolsters case for long-acting HIV PrEP drug Apretude |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
